Global Irritable Bowel Syndrome (IBS) Therapeutics Market Insights, Forecast to 2025
Table of Contents1 Study Coverage
1.1 Irritable Bowel Syndrome (IBS) Therapeutics Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Irritable Bowel Syndrome (IBS) Therapeutics Market Size Growth Rate by Product
1.4.2 Blautix (Strain)
1.4.3 Bekinda (IBS-D)
1.4.4 SYN-010
1.4.5 Tenapanor
1.5 Market by End User
1.5.1 Global Irritable Bowel Syndrome (IBS) Therapeutics Market Size Growth Rate by End User
1.5.2 Hospital
1.5.3 Research
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Irritable Bowel Syndrome (IBS) Therapeutics Market Size
2.1.1 Global Irritable Bowel Syndrome (IBS) Therapeutics Revenue 2014-2025
2.1.2 Global Irritable Bowel Syndrome (IBS) Therapeutics Sales 2014-2025
2.2 Irritable Bowel Syndrome (IBS) Therapeutics Growth Rate by Regions
2.2.1 Global Irritable Bowel Syndrome (IBS) Therapeutics Sales by Regions
2.2.2 Global Irritable Bowel Syndrome (IBS) Therapeutics Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Irritable Bowel Syndrome (IBS) Therapeutics Sales by Manufacturers
3.1.1 Irritable Bowel Syndrome (IBS) Therapeutics Sales by Manufacturers
3.1.2 Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share by Manufacturers
3.1.3 Global Irritable Bowel Syndrome (IBS) Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Irritable Bowel Syndrome (IBS) Therapeutics Revenue by Manufacturers
3.2.1 Irritable Bowel Syndrome (IBS) Therapeutics Revenue by Manufacturers (2014-2019)
3.2.2 Irritable Bowel Syndrome (IBS) Therapeutics Revenue Share by Manufacturers (2014-2019)
3.3 Irritable Bowel Syndrome (IBS) Therapeutics Price by Manufacturers
3.4 Irritable Bowel Syndrome (IBS) Therapeutics Manufacturing Base Distribution, Product Types
3.4.1 Irritable Bowel Syndrome (IBS) Therapeutics Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Irritable Bowel Syndrome (IBS) Therapeutics Product Type
3.4.3 Date of International Manufacturers Enter into Irritable Bowel Syndrome (IBS) Therapeutics Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Irritable Bowel Syndrome (IBS) Therapeutics Sales by Product
4.2 Global Irritable Bowel Syndrome (IBS) Therapeutics Revenue by Product
4.3 Irritable Bowel Syndrome (IBS) Therapeutics Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Irritable Bowel Syndrome (IBS) Therapeutics Breakdown Data by End User
6 North America
6.1 North America Irritable Bowel Syndrome (IBS) Therapeutics by Countries
6.1.1 North America Irritable Bowel Syndrome (IBS) Therapeutics Sales by Countries
6.1.2 North America Irritable Bowel Syndrome (IBS) Therapeutics Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Irritable Bowel Syndrome (IBS) Therapeutics by Product
6.3 North America Irritable Bowel Syndrome (IBS) Therapeutics by End User
7 Europe
7.1 Europe Irritable Bowel Syndrome (IBS) Therapeutics by Countries
7.1.1 Europe Irritable Bowel Syndrome (IBS) Therapeutics Sales by Countries
7.1.2 Europe Irritable Bowel Syndrome (IBS) Therapeutics Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Irritable Bowel Syndrome (IBS) Therapeutics by Product
7.3 Europe Irritable Bowel Syndrome (IBS) Therapeutics by End User
8 Asia Pacific
8.1 Asia Pacific Irritable Bowel Syndrome (IBS) Therapeutics by Countries
8.1.1 Asia Pacific Irritable Bowel Syndrome (IBS) Therapeutics Sales by Countries
8.1.2 Asia Pacific Irritable Bowel Syndrome (IBS) Therapeutics Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Irritable Bowel Syndrome (IBS) Therapeutics by Product
8.3 Asia Pacific Irritable Bowel Syndrome (IBS) Therapeutics by End User
9 Central & South America
9.1 Central & South America Irritable Bowel Syndrome (IBS) Therapeutics by Countries
9.1.1 Central & South America Irritable Bowel Syndrome (IBS) Therapeutics Sales by Countries
9.1.2 Central & South America Irritable Bowel Syndrome (IBS) Therapeutics Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Irritable Bowel Syndrome (IBS) Therapeutics by Product
9.3 Central & South America Irritable Bowel Syndrome (IBS) Therapeutics by End User
10 Middle East and Africa
10.1 Middle East and Africa Irritable Bowel Syndrome (IBS) Therapeutics by Countries
10.1.1 Middle East and Africa Irritable Bowel Syndrome (IBS) Therapeutics Sales by Countries
10.1.2 Middle East and Africa Irritable Bowel Syndrome (IBS) Therapeutics Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Irritable Bowel Syndrome (IBS) Therapeutics by Product
10.3 Middle East and Africa Irritable Bowel Syndrome (IBS) Therapeutics by End User
11 Company Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Company Business Overview
11.1.3 Abbott Laboratories Irritable Bowel Syndrome (IBS) Therapeutics Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Abbott Laboratories Irritable Bowel Syndrome (IBS) Therapeutics Products Offered
11.1.5 Abbott Laboratories Recent Development
11.2 Synergy Pharmaceuticals
11.2.1 Synergy Pharmaceuticals Company Details
11.2.2 Company Business Overview
11.2.3 Synergy Pharmaceuticals Irritable Bowel Syndrome (IBS) Therapeutics Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Synergy Pharmaceuticals Irritable Bowel Syndrome (IBS) Therapeutics Products Offered
11.2.5 Synergy Pharmaceuticals Recent Development
11.3 Sucampo Pharmaceuticals
11.3.1 Sucampo Pharmaceuticals Company Details
11.3.2 Company Business Overview
11.3.3 Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Therapeutics Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Therapeutics Products Offered
11.3.5 Sucampo Pharmaceuticals Recent Development
11.4 Valeant Pharmaceuticals International
11.4.1 Valeant Pharmaceuticals International Company Details
11.4.2 Company Business Overview
11.4.3 Valeant Pharmaceuticals International Irritable Bowel Syndrome (IBS) Therapeutics Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Valeant Pharmaceuticals International Irritable Bowel Syndrome (IBS) Therapeutics Products Offered
11.4.5 Valeant Pharmaceuticals International Recent Development
11.5 Ardelyx
11.5.1 Ardelyx Company Details
11.5.2 Company Business Overview
11.5.3 Ardelyx Irritable Bowel Syndrome (IBS) Therapeutics Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Ardelyx Irritable Bowel Syndrome (IBS) Therapeutics Products Offered
11.5.5 Ardelyx Recent Development
11.6 Astellas Pharma
11.6.1 Astellas Pharma Company Details
11.6.2 Company Business Overview
11.6.3 Astellas Pharma Irritable Bowel Syndrome (IBS) Therapeutics Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Astellas Pharma Irritable Bowel Syndrome (IBS) Therapeutics Products Offered
11.6.5 Astellas Pharma Recent Development
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Company Business Overview
11.7.3 Novartis Irritable Bowel Syndrome (IBS) Therapeutics Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Novartis Irritable Bowel Syndrome (IBS) Therapeutics Products Offered
11.7.5 Novartis Recent Development
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Company Details
11.8.2 Company Business Overview
11.8.3 GlaxoSmithKline Irritable Bowel Syndrome (IBS) Therapeutics Sales, Revenue and Gross Margin (2014-2019)
11.8.4 GlaxoSmithKline Irritable Bowel Syndrome (IBS) Therapeutics Products Offered
11.8.5 GlaxoSmithKline Recent Development
11.9 Ironwood Pharmaceuticals
11.9.1 Ironwood Pharmaceuticals Company Details
11.9.2 Company Business Overview
11.9.3 Ironwood Pharmaceuticals Irritable Bowel Syndrome (IBS) Therapeutics Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Ironwood Pharmaceuticals Irritable Bowel Syndrome (IBS) Therapeutics Products Offered
11.9.5 Ironwood Pharmaceuticals Recent Development
12 Future Forecast
12.1 Irritable Bowel Syndrome (IBS) Therapeutics Market Forecast by Regions
12.1.1 Global Irritable Bowel Syndrome (IBS) Therapeutics Sales Forecast by Regions 2019-2025
12.1.2 Global Irritable Bowel Syndrome (IBS) Therapeutics Revenue Forecast by Regions 2019-2025
12.2 Irritable Bowel Syndrome (IBS) Therapeutics Market Forecast by Product
12.2.1 Global Irritable Bowel Syndrome (IBS) Therapeutics Sales Forecast by Product 2019-2025
12.2.2 Global Irritable Bowel Syndrome (IBS) Therapeutics Revenue Forecast by Product 2019-2025
12.3 Irritable Bowel Syndrome (IBS) Therapeutics Market Forecast by End User
12.4 North America Irritable Bowel Syndrome (IBS) Therapeutics Forecast
12.5 Europe Irritable Bowel Syndrome (IBS) Therapeutics Forecast
12.6 Asia Pacific Irritable Bowel Syndrome (IBS) Therapeutics Forecast
12.7 Central & South America Irritable Bowel Syndrome (IBS) Therapeutics Forecast
12.8 Middle East and Africa Irritable Bowel Syndrome (IBS) Therapeutics Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Irritable Bowel Syndrome (IBS) Therapeutics Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and FiguresFigure Irritable Bowel Syndrome (IBS) Therapeutics Product Picture
Table Irritable Bowel Syndrome (IBS) Therapeutics Market Segments
Table Key Manufacturers Irritable Bowel Syndrome (IBS) Therapeutics Covered
Table Global Irritable Bowel Syndrome (IBS) Therapeutics Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share by Product 2014-2025
Figure Blautix (Strain) Product Picture
Table Major Manufacturers of Blautix (Strain)
Figure Bekinda (IBS-D) Product Picture
Table Major Manufacturers of Bekinda (IBS-D)
Figure SYN-010 Product Picture
Table Major Manufacturers of SYN-010
Figure Tenapanor Product Picture
Table Major Manufacturers of Tenapanor
Table Global Irritable Bowel Syndrome (IBS) Therapeutics Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Hospital
Figure Research
Figure Irritable Bowel Syndrome (IBS) Therapeutics Report Years Considered
Figure Global Irritable Bowel Syndrome (IBS) Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Irritable Bowel Syndrome (IBS) Therapeutics Sales 2014-2025 (K Units)
Table Global Irritable Bowel Syndrome (IBS) Therapeutics Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Irritable Bowel Syndrome (IBS) Therapeutics Sales by Regions 2014-2019 (K Units)
Table Global Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share by Regions 2014-2019
Figure Global Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share by Regions 2014-2019
Figure 2018 Global Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share by Regions
Table Global Irritable Bowel Syndrome (IBS) Therapeutics Revenue by Regions 2014-2019 (Million US$)
Table Global Irritable Bowel Syndrome (IBS) Therapeutics Revenue Market Share by Regions 2014-2019
Figure Global Irritable Bowel Syndrome (IBS) Therapeutics Revenue Market Share by Regions 2014-2019
Figure 2018 Global Irritable Bowel Syndrome (IBS) Therapeutics Revenue Market Share by Regions
Table Global Irritable Bowel Syndrome (IBS) Therapeutics Sales by Manufacturers (2014-2019) (K Units)
Table Global Irritable Bowel Syndrome (IBS) Therapeutics Sales Share by Manufacturers (2014-2019)
Figure Global Irritable Bowel Syndrome (IBS) Therapeutics Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Irritable Bowel Syndrome (IBS) Therapeutics Revenue by Manufacturers (2014-2019) (Million USD)
Table Irritable Bowel Syndrome (IBS) Therapeutics Revenue Share by Manufacturers (2014-2019)
Figure Irritable Bowel Syndrome (IBS) Therapeutics Value Share by Manufacturers in 2018
Table Key Manufacturers Irritable Bowel Syndrome (IBS) Therapeutics Price (2014-2019) (USD/Unit)
Table Irritable Bowel Syndrome (IBS) Therapeutics Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Irritable Bowel Syndrome (IBS) Therapeutics Product Type
Table Date of International Manufacturers Enter into Irritable Bowel Syndrome (IBS) Therapeutics Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Irritable Bowel Syndrome (IBS) Therapeutics Sales by Product (2014-2019) (K Units)
Table Global Irritable Bowel Syndrome (IBS) Therapeutics Sales Share by Product (2014-2019)
Figure Global Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share by Product (2014-2019)
Figure Global Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share by Product in 2018
Table Global Irritable Bowel Syndrome (IBS) Therapeutics Revenue by Product (2014-2019) (Million US$)
Table Global Irritable Bowel Syndrome (IBS) Therapeutics Revenue Share by Product (2014-2019)
Figure Global Irritable Bowel Syndrome (IBS) Therapeutics Revenue Market Share by Product (2014-2019)
Figure Global Irritable Bowel Syndrome (IBS) Therapeutics Revenue Market Share by Product in 2018
Table Irritable Bowel Syndrome (IBS) Therapeutics Price by Product 2014-2019 (USD/Unit)
Table Global Irritable Bowel Syndrome (IBS) Therapeutics Sales by End User (2014-2019) (K Units)
Table Global Irritable Bowel Syndrome (IBS) Therapeutics Sales Share by End User (2014-2019)
Figure Global Sales Irritable Bowel Syndrome (IBS) Therapeutics Market Share by End User (2014-2019)
Figure Global Sales Irritable Bowel Syndrome (IBS) Therapeutics Market Share by End User in 2018
Figure North America Irritable Bowel Syndrome (IBS) Therapeutics Sales Growth Rate 2014-2019 (K Units)
Figure North America Irritable Bowel Syndrome (IBS) Therapeutics Revenue Growth Rate 2014-2019 (Million US$)
Table North America Irritable Bowel Syndrome (IBS) Therapeutics Sales by Countries (2014-2019) (K Units)
Table North America Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share by Countries (2014-2019)
Figure 2018 North America Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share by Countries
Table North America Irritable Bowel Syndrome (IBS) Therapeutics Revenue by Countries (2014-2019) (Million US$)
Table North America Irritable Bowel Syndrome (IBS) Therapeutics Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Irritable Bowel Syndrome (IBS) Therapeutics Revenue Market Share by Countries
Figure United States Irritable Bowel Syndrome (IBS) Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure United States Irritable Bowel Syndrome (IBS) Therapeutics Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Irritable Bowel Syndrome (IBS) Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure Canada Irritable Bowel Syndrome (IBS) Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Irritable Bowel Syndrome (IBS) Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Irritable Bowel Syndrome (IBS) Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Table North America Irritable Bowel Syndrome (IBS) Therapeutics Sales by Product (2014-2019) (K Units)
Table North America Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share by Product (2014-2019)
Figure 2018 North America Irritable Bowel Syndrome (IBS) Therapeutics Market Share by Product
Table North America Irritable Bowel Syndrome (IBS) Therapeutics Sales by End User (2014-2019) (K Units)
Table North America Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share by End User (2014-2019)
Figure 2018 North America Irritable Bowel Syndrome (IBS) Therapeutics Market Share by End User
Figure Europe Irritable Bowel Syndrome (IBS) Therapeutics Sales Growth Rate 2014-2019 (K Units)
Figure Europe Irritable Bowel Syndrome (IBS) Therapeutics Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Irritable Bowel Syndrome (IBS) Therapeutics Sales by Countries (2014-2019) (K Units)
Table Europe Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share by Countries
Table Europe Irritable Bowel Syndrome (IBS) Therapeutics Revenue by Countries (2014-2019) (Million US$)
Table Europe Irritable Bowel Syndrome (IBS) Therapeutics Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Irritable Bowel Syndrome (IBS) Therapeutics Revenue Market Share by Countries
Figure Germany Irritable Bowel Syndrome (IBS) Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure Germany Irritable Bowel Syndrome (IBS) Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure France Irritable Bowel Syndrome (IBS) Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure France Irritable Bowel Syndrome (IBS) Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Irritable Bowel Syndrome (IBS) Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure UK Irritable Bowel Syndrome (IBS) Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Irritable Bowel Syndrome (IBS) Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure Italy Irritable Bowel Syndrome (IBS) Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Irritable Bowel Syndrome (IBS) Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure Russia Irritable Bowel Syndrome (IBS) Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Irritable Bowel Syndrome (IBS) Therapeutics Sales by Product (2014-2019) (K Units)
Table Europe Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share by Product (2014-2019)
Figure 2018 Europe Irritable Bowel Syndrome (IBS) Therapeutics Market Share by Product
Table Europe Irritable Bowel Syndrome (IBS) Therapeutics Sales by End User (2014-2019) (K Units)
Table Europe Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share by End User (2014-2019)
Figure 2018 Europe Irritable Bowel Syndrome (IBS) Therapeutics Market Share by End User
Figure Asia Pacific Irritable Bowel Syndrome (IBS) Therapeutics Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Irritable Bowel Syndrome (IBS) Therapeutics Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Irritable Bowel Syndrome (IBS) Therapeutics Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share by Countries
Table Asia Pacific Irritable Bowel Syndrome (IBS) Therapeutics Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Irritable Bowel Syndrome (IBS) Therapeutics Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Irritable Bowel Syndrome (IBS) Therapeutics Revenue Market Share by Countries
Figure China Irritable Bowel Syndrome (IBS) Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure China Irritable Bowel Syndrome (IBS) Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Irritable Bowel Syndrome (IBS) Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure Japan Irritable Bowel Syndrome (IBS) Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Irritable Bowel Syndrome (IBS) Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure Korea Irritable Bowel Syndrome (IBS) Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure India Irritable Bowel Syndrome (IBS) Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure India Irritable Bowel Syndrome (IBS) Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Irritable Bowel Syndrome (IBS) Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure Australia Irritable Bowel Syndrome (IBS) Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Irritable Bowel Syndrome (IBS) Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Irritable Bowel Syndrome (IBS) Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Irritable Bowel Syndrome (IBS) Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Irritable Bowel Syndrome (IBS) Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Irritable Bowel Syndrome (IBS) Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Irritable Bowel Syndrome (IBS) Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Irritable Bowel Syndrome (IBS) Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Irritable Bowel Syndrome (IBS) Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Irritable Bowel Syndrome (IBS) Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Irritable Bowel Syndrome (IBS) Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Irritable Bowel Syndrome (IBS) Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Irritable Bowel Syndrome (IBS) Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Irritable Bowel Syndrome (IBS) Therapeutics Sales by Product (2014-2019) (K Units)
Table Asia Pacific Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Irritable Bowel Syndrome (IBS) Therapeutics Market Share by Product
Table Asia Pacific Irritable Bowel Syndrome (IBS) Therapeutics Sales by End User (2014-2019) (K Units)
Table Asia Pacific Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Irritable Bowel Syndrome (IBS) Therapeutics Market Share by End User
Figure Central & South America Irritable Bowel Syndrome (IBS) Therapeutics Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Irritable Bowel Syndrome (IBS) Therapeutics Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Irritable Bowel Syndrome (IBS) Therapeutics Sales by Countries (2014-2019) (K Units)
Table Central & South America Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share by Countries
Table Central & South America Irritable Bowel Syndrome (IBS) Therapeutics Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Irritable Bowel Syndrome (IBS) Therapeutics Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Irritable Bowel Syndrome (IBS) Therapeutics Revenue Market Share by Countries
Figure Brazil Irritable Bowel Syndrome (IBS) Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Irritable Bowel Syndrome (IBS) Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Irritable Bowel Syndrome (IBS) Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Irritable Bowel Syndrome (IBS) Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Irritable Bowel Syndrome (IBS) Therapeutics Sales by Product (2014-2019) (K Units)
Table Central & South America Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Irritable Bowel Syndrome (IBS) Therapeutics Market Share by Product
Table Central & South America Irritable Bowel Syndrome (IBS) Therapeutics Sales by End User (2014-2019) (K Units)
Table Central & South America Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Irritable Bowel Syndrome (IBS) Therapeutics Market Share by End User
Figure Middle East and Africa Irritable Bowel Syndrome (IBS) Therapeutics Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Irritable Bowel Syndrome (IBS) Therapeutics Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Irritable Bowel Syndrome (IBS) Therapeutics Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share by Countries
Table Middle East and Africa Irritable Bowel Syndrome (IBS) Therapeutics Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Irritable Bowel Syndrome (IBS) Therapeutics Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Irritable Bowel Syndrome (IBS) Therapeutics Revenue Market Share by Countries
Figure GCC Countries Irritable Bowel Syndrome (IBS) Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Irritable Bowel Syndrome (IBS) Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Irritable Bowel Syndrome (IBS) Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Irritable Bowel Syndrome (IBS) Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Irritable Bowel Syndrome (IBS) Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Irritable Bowel Syndrome (IBS) Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Irritable Bowel Syndrome (IBS) Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Irritable Bowel Syndrome (IBS) Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Irritable Bowel Syndrome (IBS) Therapeutics Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Irritable Bowel Syndrome (IBS) Therapeutics Market Share by Product
Table Middle East and Africa Irritable Bowel Syndrome (IBS) Therapeutics Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Irritable Bowel Syndrome (IBS) Therapeutics Market Share by End User
Table Abbott Laboratories Company Details
Table Abbott Laboratories Irritable Bowel Syndrome (IBS) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Abbott Laboratories Recent Development
Table Synergy Pharmaceuticals Company Details
Table Synergy Pharmaceuticals Irritable Bowel Syndrome (IBS) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Synergy Pharmaceuticals Recent Development
Table Sucampo Pharmaceuticals Company Details
Table Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Sucampo Pharmaceuticals Recent Development
Table Valeant Pharmaceuticals International Company Details
Table Valeant Pharmaceuticals International Irritable Bowel Syndrome (IBS) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Valeant Pharmaceuticals International Recent Development
Table Ardelyx Company Details
Table Ardelyx Irritable Bowel Syndrome (IBS) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Ardelyx Recent Development
Table Astellas Pharma Company Details
Table Astellas Pharma Irritable Bowel Syndrome (IBS) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Astellas Pharma Recent Development
Table Novartis Company Details
Table Novartis Irritable Bowel Syndrome (IBS) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Irritable Bowel Syndrome (IBS) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table GlaxoSmithKline Recent Development
Table Ironwood Pharmaceuticals Company Details
Table Ironwood Pharmaceuticals Irritable Bowel Syndrome (IBS) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Ironwood Pharmaceuticals Recent Development
Table Global Irritable Bowel Syndrome (IBS) Therapeutics Sales Forecast by Regions 2019-2025 (K Units)
Table Global Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share Forecast by Regions 2019-2025
Table Global Irritable Bowel Syndrome (IBS) Therapeutics Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Irritable Bowel Syndrome (IBS) Therapeutics Revenue Market Share Forecast by Regions 2019-2025
Table Global Irritable Bowel Syndrome (IBS) Therapeutics Sales Forecast by Product 2019-2025 (K Units)
Table Global Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share Forecast by Product 2019-2025
Table Global Irritable Bowel Syndrome (IBS) Therapeutics Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Irritable Bowel Syndrome (IBS) Therapeutics Revenue Market Share Forecast by Product 2019-2025
Table Global Irritable Bowel Syndrome (IBS) Therapeutics Sales Forecast by End User 2019-2025 (K Units)
Table Global Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share Forecast by End User 2019-2025
Figure North America Irritable Bowel Syndrome (IBS) Therapeutics Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Irritable Bowel Syndrome (IBS) Therapeutics Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Irritable Bowel Syndrome (IBS) Therapeutics Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Irritable Bowel Syndrome (IBS) Therapeutics Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Irritable Bowel Syndrome (IBS) Therapeutics Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Irritable Bowel Syndrome (IBS) Therapeutics Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Irritable Bowel Syndrome (IBS) Therapeutics Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Irritable Bowel Syndrome (IBS) Therapeutics Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Irritable Bowel Syndrome (IBS) Therapeutics Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Irritable Bowel Syndrome (IBS) Therapeutics Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Irritable Bowel Syndrome (IBS) Therapeutics Value Chain
Table Irritable Bowel Syndrome (IBS) Therapeutics Customers List
Table Irritable Bowel Syndrome (IBS) Therapeutics Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources